My teacher
Release time:
2020-08-14
My teacher
■ Pharmaceutical Company Fan Tufa
people's life, from young to old, from ignorance to knowledge, has been taught by many teachers. Teachers in various classes in their school days need not say, those good teachers and helpful friends they met after taking part in the work, it will also become a very important part of your life and may eventually become an indispensable part of your entire career. I have been in Jianfeng Group for more than 30 years. It is because of the generous advice of many predecessors that I have been able to grow and mature.
1981 In July, after graduating from Senior high school, I entered Jinhua Cement Factory, the predecessor of Jianfeng Group Company. At that time, high school students were still "cultural people". I was assigned to the factory infirmary and studied medicine from scratch. At that time, Dr. Xu Fukang, the director of the infirmary, became my first medical teacher.
Because I have no medical foundation, I have to learn from the doctors on duty every day. In my spare time, Dr. Xu Fukang explained to me the basic knowledge of diagnosis and treatment of patients who were treated on that day. He also lent me basic medical books and told me to read more in my spare time after work. I should learn more, listen more, read more and take notes frequently. He not only asked me to learn book knowledge well, but also taught me various basic clinical skills hand in hand, such as intramuscular injection, static injection, debridement, suture, bandaging, etc., and explained in detail the essentials and precautions of various operations. Take the simple intramuscular injection of buttocks as an example. On the surface, the operation is really simple. It is enough to inject the liquid medicine after the needle is inserted. However, in Dr. Xu's view, this seemingly simple thing also requires a solid foundation and a serious attitude. In addition to the necessary strict disinfection and "three checks and seven pairs", we should also master the skills not available in books, for example, the thumb and index finger of the left hand fix the injection site and tighten the skin, the right hand should pay attention to the front and back positions of the syringe, and the small thenar of the right palm should just hit the patient's hip while the needle vertically pierces the skin, which can disperse the pain of the patient. While pushing the liquid medicine slowly and uniformly, the left hand can also gently scratch around the injection site to distract the patient's attention and help them relax.
One day, aunt Hu chunxing, an old employee, came to the infirmary for an injection. she happened to meet dr Xu telling me the essentials of the injection. she offered to let me give her an injection. Seeing that I was a little timid, she also encouraged me to be bold and careful, apply what I have learned and not be nervous. In this way, I completed my first injection operation on aunt Hu chunxing. Looking back now, I am still grateful to Aunt Hu Chunxing. It is her encouragement and dedication that inspired me to continue to learn and grow in my future work.
After that, I systematically learned medical related knowledge and obtained the qualification of medical practitioner through self-study and going out to participate in training. In the peak of more than 30 years, I have also received the help and guidance of many leaders and colleagues in different periods, so that my experience and skills have been continuously enriched and improved. Although I do not take the position of practicing physician as my main job content, the work skills and work attitude learned from the older generation of peak employees such as Xu Fukang and Hu Chunxing are still the motivation and direction of my future work, which is worth remembering for life. They left their jobs because of their age, but their spirit of selfless dedication is still passed on from generation to generation, inspiring us to keep moving forward and achieve the great cause of "a century of peak.
On the occasion of celebrating the 60th anniversary of Jianfeng Group's establishment, I wish all the old employees who have worked hard all their lives for Jianfeng's business good health and happiness in their old age, and wish Jianfeng Group another brilliant innovation.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page